Skip to Content
U.S. National Institutes of Health

CDP Funded Technology Development Studies in FY2001

R21 and R33 Grants Awarded by CDP in Response to PAR-99-100, Innovative Technologies for the Molecular Analysis of Cancer: Phased Innovation Award (R21/R33)

(PAR-99-100 has been superseded by PAR-01-104, Innovative Technologies for the Molecular Analysis of Cancer: Phases Innovation Award)

Faris, Gregory W, PhD
Upconverting Chelates for Cancer Detection and Diagnosis
SRI International, Menlo Park, CA

Farkas, Daniel L, PhD
Cancer Molecule Analysis by AOTF Multispectral Imaging
University of Pittsburgh at Pittsburgh, Pittsburgh, PA

Fresco, Jacques R, PhD
Fluorescent TISH Probes for Cancer-relevant Sequences
Princeton University, Princeton, NJ

Guo, Baochuan, PhD
MALDI-TOF Technology for Molecular Analysis of Cancer
Cleveland State University, Cleveland, OH

Lieber, Charles M, PhD
Carbon Nanotube Probes for Direct DNA Sequence Analysis
Harvard University, Cambridge, MA

Sikic, Branimir I, MD
Gene Expression Profiling of Unknown Primary Cancers
Stanford University, Stanford, CA

Yamamoto, Fumiichiro, PhD
New Technology to Detect Genome-wide DNA Methylation Changes
The Burnham Institute, La Jolla, CA

See More:
All NCI awards in response to PAR-99-100 in FY 2001.

R43 and R44 Grants Awarded by CDP in Response to PAR-99-101, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR Initiative

(PAR-99-101 has been superseded by PAR-01-105, Innovative Technologies for the Molecular Analysis of Cancer: SBIR/STTR)

Gao, Jun, PhD
2-D Microfluidic Gene Scanner
Calibrant Biosystems, Bethesda, MD

Johnson, Paul H, PhD
Whole Genome Methylation Assay
EpiGenX Pharmaceuticals, Inc., Santa Barbara, CA

Rao, Chandra, PhD
Analysis of Circulating Cancer Cells Early in Disease
Immunicon Corporation, Huntingdon Valley, PA

Shen, Shanxiang, PhD
Microcantilever Array Device for Protein Profiling
Protiveris, Inc., Rockville, MD

Wang, Jiwu, PhD
Innovative RNA Profiling in Cancer Cells
Allele Biotechnolgy & Pharmaceuticals, Inc., San Diego, CA

See More:
All NCI awards in response to PAR-99-101 in FY 2001.

R21 Grant Awarded by CDP in Response to PAR-99-102, Applications of Innovative Technologies for the Molecular Analysis of Cancer: Phased Technology Application Award (R21/R33)

(PAR-99-102 has been superseded by PAR-01-106, Applications of Innovative Technologies for the Molecular Analysis of Caoncer: Phased Innovation Award)

Parkos, Charles A, MD, PhD
Phage Display and Prostate Neoplasia Progression
Emory University, Atlanta, GA

See More:
All NCI awards in response to PAR-99-102 and PAR-99-103 in FY 2001.

R21 and R33 Grants Awarded in Response to RFA CA01-011, Technologies for Comprehensive, Sensitive, and Quantitative Protein Analysis in Human Tumors: Phased Innovation

Aebersold, Ruedi H, PhD
A Novel Quantitative, Comprehensive Proteomic Technology
Institute for Systems Biology, Seattle, WA

Ellington, Andrew D, PhD
Lipid Affinity Proteomics Analysis of Human Tumors
University of Texas at Austin, Austin, TX

Hanash, Samir M, MD
A Tagged Protein Approach for Proteome Analysis to Enhance Sensitivity for Membrane Proteins
University of Michigan, Ann Arbor, MI

Kodadek, Thomas J, PhD
Development of Protein-Detecting Microarrays
UT Southwestern Medical Center at Dallas, Dallas, TX

Patton, Wayne F, PhD
Dichromatic Fluorescence Proteomics for Cancer Tissue
Molecular Probes, Inc., Eugene, OR

Smith, Richard D, PhD
Technology for Global and Quantitative Proteome Analysis of Human Tumors
Battelle Memorial Institute, Richland, WA